Smad4 and p53 synergize in suppressing autochthonous intestinal cancer

Jun Won Park1,2, Min-Jung Seo1, Kye Soo Cho1,3

  • 1National Cancer Center, Goyang, Republic of Korea.

Cancer Medicine
|March 11, 2022
PubMed
Abstract

Insights

Smad4 and p53 mutations synergistically drive intestinal cancer by downregulating p21 and activating the Wnt pathway. Targeting Wnt signaling with inhibitors like CWP232291 suppressed tumor growth and cancer stem cells.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Colorectal cancers (CRCs) frequently harbor mutations in Smad4 and p53.
  • The synergistic role of these common mutations in intestinal carcinogenesis remains incompletely understood.

Purpose of the Study:

  • To investigate the synergistic effects of Smad4 and p53 loss in intestinal carcinogenesis.
  • To elucidate the molecular mechanisms underlying this synergy.

Main Methods:

  • Generation of novel autochthonous mouse models (Villin-Cre;Smad4F/F;Trp53F/F) to recapitulate human CRCs.
  • Comparative analysis of intestinal phenotypes and molecular markers between different genetically modified mouse groups.
  • Treatment with a small-molecule Wnt inhibitor (CWP232291) and a Bcl-XL antagonist (BH3I-1) to assess therapeutic efficacy.

Main Results:

  • Villin-Cre;Smad4F/F;Trp53F/F mice developed spontaneous, highly proliferative intestinal tumors and adenocarcinomas.
  • Loss of Smad4 and p53 led to p21 downregulation and Wnt/β-catenin pathway activation.
  • Wnt inhibition suppressed tumor progression, reduced cancer stem cell (CSC) markers (CD133, Lgr-5, Sca-1), and decreased CSC frequency.
  • Bcl-XL antagonism further inhibited intestinal CSCs.

Conclusions:

  • Smad4 and p53 loss act synergistically in driving intestinal carcinogenesis.
  • The synergistic effect involves p21 downregulation and Wnt/β-catenin pathway activation.
  • Targeting the Wnt pathway and Bcl-XL shows therapeutic potential against Smad4/p53-mutated colorectal cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K